← Back to EC filing summaryThis is the extracted source text from the SEC filing. Formatting may differ from the original document.
A. Operating Results 3.4 – 3.8; 4
B. Liquidity and Capital Resources 2.1; 4.7; Consolidated statements of cash flow and Notes 6, 9, 20, and 29 to the consolidated financial statements
C. Research and development, Patents and Licenses, etc. 3.9; Note 17 to the consolidated financial statements
D. Trend Information 4.12
E. Critical Accounting Estimates 4.5; Note 3 to the consolidated financial statements